Examples
Worked examples
- Is an instance
A multi-year clinical study's REB-approved consent form includes a standing clause obligating the study team to notify enrolled participants of newly discovered risks and to offer re-consent or withdrawal if the protocol changes materially -- operationalizing the 'ongoing' prong of Article 3.1, not just the initial signature.
- Is an instance
A professor who wants to recruit their own current students as research participants builds in extra safeguards -- third-party recruitment, an explicit assurance that declining carries no academic consequence, no involvement in grading during the study -- because the professor-student relationship is exactly the kind of dependency relationship Article 3.1 flags for heightened REB scrutiny of undue influence.
Counter-examples
Looks similar, but isn't
- Not an instance
A study that treats consent as complete once a participant signs an intake form, with no mechanism for informing them of materially changed risks over the course of a multi-year study, does not on its own satisfy Article 3.1 -- TCPS 2 frames consent as an ongoing process, and a one-time signature captured at intake is only the starting point, not the whole requirement.
Editorial commentary
Article 3.1 of Canada’s Tri-Council Policy Statement (TCPS 2) is the foundational articulation of free and informed consent for research involving human participants funded or hosted under the Tri-Agency framework (CIHR, NSERC, SSHRC). It sits in Chapter 3, “The Consent Process,” and works alongside Article 2.1, which establishes when a project requires REB review in the first place — Article 2.1 answers “does this need REB review,” and Article 3.1 answers “what does a valid consent process for that review look like.”
The three prongs: free, informed, ongoing
TCPS 2 uses “consent” throughout the Policy as shorthand for “free, informed, and ongoing consent,” and Article 3.1 is where that compound standard is set out in operational terms:
- Free. Consent must be voluntary, given without manipulation, undue influence, or coercion. REBs are specifically directed to scrutinize trust or dependency relationships — physician-patient, employer-employee, professor-student — where the relationship itself could pressure someone into agreeing.
- Informed. The prospective participant needs enough information, in understandable language, about the research’s purpose, procedures, reasonably foreseeable risks, and potential benefits to make a genuine decision about whether to take part.
- Ongoing. Consent is not a single event. Researchers carry a continuing obligation to disclose material changes in risk or benefit as a study proceeds, and to revisit consent — or offer withdrawal — when those changes are significant enough to affect a participant’s earlier decision.
That third prong is the detail most worth flagging for anyone coming from a US regulatory background: TCPS 2 explicitly frames consent as a process that continues for the duration of a participant’s involvement, not a form signed once at intake. CASRAI’s guide on informed consent timing covers the same conceptual ground — re-consent triggers, ongoing disclosure obligations — for a US audience; Article 3.1 is the Canadian regulatory anchor for that same principle.
How this compares to the US Common Rule
The US Common Rule (45 CFR 46.116) shares the same substantive goals — voluntariness, comprehension, disclosure of material information — and both frameworks trace back to the same research-ethics lineage (respect for persons, as articulated in the 1979 Belmont Report, which directly informed the Common Rule’s consent requirements). But the two instruments differ in form and framing:
- Legal status. TCPS 2 is a tri-agency funding policy, binding on institutions through their funding agreements with CIHR, NSERC, and SSHRC, and enforced institutionally through REBs. The Common Rule is binding federal regulation (45 CFR Part 46) directly enforceable by HHS/OHRP against covered institutions.
- Structure of the consent requirement. 45 CFR 46.116 sets out consent as a checklist of required and additional elements to be disclosed at the time consent is obtained, with signature documentation governed separately under 45 CFR 46.117. Article 3.1 folds the equivalent disclosure content into a broader three-part standard (free / informed / ongoing) that treats the passage of time and the possibility of a changing risk profile as part of the core requirement itself, not an ancillary re-consent procedure layered on top.
- Relationship-based scrutiny. Article 3.1 names dependency relationships explicitly as a factor REBs must weigh. The Common Rule addresses comparable concerns (e.g., protections for prisoners, students, employees as a class) but primarily through separate subparts and IRB-level judgment on voluntariness, rather than a single consent article naming the dependency dynamic directly.
In practice, a consent process built to satisfy 45 CFR 46.116 will generally cover most of what Article 3.1 requires substantively — but a researcher moving a US-designed protocol to a Canadian REB should expect the REB to ask specifically how the study handles ongoing disclosure and re-consent over time, since TCPS 2 makes that an explicit, named requirement rather than a matter left to the study’s own risk-management judgment.
Related terms and guides
- TCPS 2 Article 2.1 (REB Review Requirement) — the threshold test for whether a project needs REB review at all.
- TCPS2 (Tri-Council Policy Statement) — the parent policy.
- Common Rule (45 CFR 46) — the US regulatory analogue.
- Informed Consent in Research: What It Requires and How It Works — general treatment of informed consent as a concept.
- When Should Informed Consent Be Obtained? Timing, Re-Consent, and the Emergency Exception — US-focused companion piece on the same ongoing-consent principle.
Machine-readable encodings
Use in your systems
<role vocab="credit"
vocab-identifier="https://casrai.org/dictionary/"
vocab-term="TCPS 2 Article 3.1 (Free and Informed Consent)"
vocab-term-identifier="https://casrai.org/dictionary/term/tcps2-article-3-1-free-and-informed-consent" />{
"@context": "https://schema.org",
"@type": "DefinedTerm",
"@id": "https://casrai.org/dictionary/term/tcps2-article-3-1-free-and-informed-consent",
"name": "TCPS 2 Article 3.1 (Free and Informed Consent)",
"identifier": "https://casrai.org/dictionary/term/tcps2-article-3-1-free-and-informed-consent",
"description": "TCPS 2 (the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, 2022 edition) Article 3.1, in Chapter 3 ('The Consent Process'), sets out Canada's core requirement that participation in research involving human participants be based on free, informed, and ongoing consent. A consent process satisfies Article 3.1 when: (1) it is FREE -- given voluntarily, without manipulation, undue influence, or coercion; (2) it is INFORMED -- the prospective participant has enough understandable information about the research's purpose, procedures, reasonably foreseeable risks and potential benefits to make a genuine choice; and (3) it is ONGOING -- treated as a continuing process rather than a single signature, with researchers under a standing obligation to disclose material changes in risk or benefit as the study proceeds, and to reconfirm consent or offer withdrawal where warranted. Research Ethics Boards (REBs) are directed to apply particular scrutiny to trust or dependency relationships (for example, physician-patient or professor-student) where the relationship itself could create undue influence on a prospective participant's decision to take part.",
"inDefinedTermSet": "https://casrai.org/dictionary/domain/compliance-regulatory#set",
"url": "https://casrai.org/dictionary/term/tcps2-article-3-1-free-and-informed-consent",
"sameAs": [],
"license": "https://creativecommons.org/licenses/by/4.0/",
"publisher": {
"@id": "https://casrai.org/#organization"
},
"dateModified": "2026-07-23T09:04:28",
"inLanguage": "en"
}






